_id

690daf72ccc777a4e85d0b04

Ticker

AORT

Name

Artivion Inc

Exchange

NYSE

Address

1655 Roberts Boulevard NW, Kennesaw, GA, United States, 30144

Country

USA

Sector

Healthcare

Industry

Medical Devices

Currency

USD

Website

https://artivion.com

Description

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac and preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts, including E-vita Open NEO, E-vita Open Plus, ascyrus medical dissection stent hybrid prosthesis, E-vita THORACIC 3G products, and NEXUS products. It also offers E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries and aneurysmal iliac side branches; Tuva BX, a balloon-expandable peripheral stent graft to treat arterial ruptures, aneurysms, and other peripheral vascular system pathologies; and E-tegra, a stent graft system for the treatment of infrarenal abdominal aortic aneurysms. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves, and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters; Chord-X ePTFE sutures for mitral chordal replacement; and pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.

Last Close

45.48

Volume

409225

Current Price

45.12

Change

-0.7915567282321888

Last Updated

2025-11-28T12:16:43.657Z

Image

data:image/webp;base64,UklGRi4BAABXRUJQVlA4ICIBAACQCACdASpAAEAAPqlCm0mmI6KhM/zKqMAVCWIAwcP/01sgNueCLIBptbL/aVLrp9F5/G7bjaAPfphyIJNEJiM69OUGLL5Q9PnpfWAg8AD+4W6e52LxHT/+A+7/3st8Yf1zhHpgTPF+g/lteSdnuYQJFOW4fjZpcnXOYy44xEGf0CUv+GEPLsMRTBja0rVTQJD4lSjI7mm3bgEabOPgDCiIgGPKkDlh2XZfH9v8SWkVLS0q7mv6qXXZHhJAkudhlkbajKKgRU5yHu/tINvHH/6NEJB5hrlR96wZFGYcJrIAMx+cx42ZA0y3uMLbctgC2BZVE3WMrPzCz7UpDhMreXweSiiuzM4OF3vbG7Vwtiurj+XEUKVgfuPurujOJDaBNnaAAA==

Ipo Date

1993-02-12T00:00:00.000Z

Market Cap

2204355840

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.9959

Sentiment Sources

10

Rating

4.6667

Target Price

51.7143

Strong Buy

4

Buy

2

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

113388000

Cost Of Revenue

38993000

Gross Profit

74395000

Operating Expenses

61859000

Operating Income

12536000

Interest Expense

6119000

Pretax Income

7056000

Net Income

6502000

Eps

0.13330599692465403

Dividends Per Share

-

Shares Outstanding

47374939

Income Tax Expense

554000

EBITDA

18892000

Operating Margin

11.05584365188556

Total Other Income Expense Net

-5480000

Cash

73426000

Short Term Investments

-

Receivables

97369000

Inventories

90547000

Total Current Assets

283787000

Property Plant Equipment

79594000

Total Assets

857662000

Payables

16495999

Short Term Debt

5798000

Long Term Debt

214869000

Total Liabilities

418968000

Equity

438694000

Depreciation

5717000

Change In Working Capital

3239000

Cash From Operations

20512000

Capital Expenditures

4609000

Cash From Investing

-4609000

Cash From Financing

4067000

Net Change In Cash

19950000

PE

-

PB

5.016544561813017

ROE

1.4821264936379344

ROA

0.7581075062203991

FCF

15903000

Fcf Percent

0.14025293681871098

Piotroski FScore

4

Health Score

56

Deep Value Investing Score

6.5

Defensive Investing Score

6.5

Dividend Investing Score

3

Economic Moat Investing Score

5.8

Garp Investing Score

6

Growth Investing Score

5

Momentum Investing Score

3

Net Net Investing Score

2.5

Quality Investing Score

5

Value Investing Score

5.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

113388000

Quarters > 0 > income Statement > cost Of Revenue

38993000

Quarters > 0 > income Statement > gross Profit

74395000

Quarters > 0 > income Statement > operating Expenses

61859000

Quarters > 0 > income Statement > operating Income

12536000

Quarters > 0 > income Statement > interest Expense

6119000

Quarters > 0 > income Statement > pretax Income

7056000

Quarters > 0 > income Statement > net Income

6502000

Quarters > 0 > income Statement > eps

0.13330599692465403

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

48775000

Quarters > 0 > income Statement > income Tax Expense

554000

Quarters > 0 > income Statement > EBITDA

18892000

Quarters > 0 > income Statement > operating Margin

11.05584365188556

Quarters > 0 > income Statement > total Other Income Expense Net

-5480000

Quarters > 0 > balance Sheet > cash

73426000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

97369000

Quarters > 0 > balance Sheet > inventories

90547000

Quarters > 0 > balance Sheet > total Current Assets

283787000

Quarters > 0 > balance Sheet > property Plant Equipment

79594000

Quarters > 0 > balance Sheet > total Assets

857662000

Quarters > 0 > balance Sheet > payables

16495999

Quarters > 0 > balance Sheet > short Term Debt

5798000

Quarters > 0 > balance Sheet > long Term Debt

214869000

Quarters > 0 > balance Sheet > total Liabilities

418968000

Quarters > 0 > balance Sheet > equity

438694000

Quarters > 0 > cash Flow > net Income

6502000

Quarters > 0 > cash Flow > depreciation

5717000

Quarters > 0 > cash Flow > change In Working Capital

3239000

Quarters > 0 > cash Flow > cash From Operations

20512000

Quarters > 0 > cash Flow > capital Expenditures

4609000

Quarters > 0 > cash Flow > cash From Investing

-4609000

Quarters > 0 > cash Flow > cash From Financing

4067000

Quarters > 0 > cash Flow > net Change In Cash

19950000

Quarters > 0 > ratios > PE

0.13330599692465403

Quarters > 0 > ratios > PB

5.016544561813017

Quarters > 0 > ratios > ROE

1.4821264936379344

Quarters > 0 > ratios > ROA

0.7581075062203991

Quarters > 0 > ratios > FCF

15903000

Quarters > 0 > ratios > Piotroski FScore

4

Quarters > 0 > ratios > fcf Percent

0.14025293681871098

Quarters > 0 > health Score

56

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

112972000

Quarters > 1 > income Statement > cost Of Revenue

39860000

Quarters > 1 > income Statement > gross Profit

73112000

Quarters > 1 > income Statement > operating Expenses

64728000

Quarters > 1 > income Statement > operating Income

8384000

Quarters > 1 > income Statement > interest Expense

7270000

Quarters > 1 > income Statement > pretax Income

3482000

Quarters > 1 > income Statement > net Income

1345000

Quarters > 1 > income Statement > eps

0.029639913614526864

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

45378000

Quarters > 1 > income Statement > income Tax Expense

2137000

Quarters > 1 > income Statement > EBITDA

16290000

Quarters > 1 > income Statement > operating Margin

7.4213079347094855

Quarters > 1 > income Statement > total Other Income Expense Net

-4902000

Quarters > 1 > balance Sheet > cash

53476000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

101250000

Quarters > 1 > balance Sheet > inventories

86723000

Quarters > 1 > balance Sheet > total Current Assets

318820000

Quarters > 1 > balance Sheet > property Plant Equipment

79776000

Quarters > 1 > balance Sheet > total Assets

838387000

Quarters > 1 > balance Sheet > payables

19426000

Quarters > 1 > balance Sheet > short Term Debt

5739000

Quarters > 1 > balance Sheet > long Term Debt

215538000

Quarters > 1 > balance Sheet > total Liabilities

418485000

Quarters > 1 > balance Sheet > equity

419902000

Quarters > 1 > cash Flow > net Income

1343000

Quarters > 1 > cash Flow > depreciation

5538000

Quarters > 1 > cash Flow > change In Working Capital

-866000

Quarters > 1 > cash Flow > cash From Operations

15011000

Quarters > 1 > cash Flow > capital Expenditures

3287000

Quarters > 1 > cash Flow > cash From Investing

-3287000

Quarters > 1 > cash Flow > cash From Financing

2598000

Quarters > 1 > cash Flow > net Change In Cash

15783000

Quarters > 1 > ratios > PE

0.029639913614526864

Quarters > 1 > ratios > PB

4.876031454958538

Quarters > 1 > ratios > ROE

0.3203128348995718

Quarters > 1 > ratios > ROA

0.1604271058592273

Quarters > 1 > ratios > FCF

11724000

Quarters > 1 > ratios > Piotroski FScore

4

Quarters > 1 > ratios > fcf Percent

0.1037779272740148

Quarters > 1 > health Score

51

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

98978000

Quarters > 2 > income Statement > cost Of Revenue

35401000

Quarters > 2 > income Statement > gross Profit

63577000

Quarters > 2 > income Statement > operating Expenses

61432000

Quarters > 2 > income Statement > operating Income

2145000

Quarters > 2 > income Statement > interest Expense

7663000

Quarters > 2 > income Statement > pretax Income

-2295000

Quarters > 2 > income Statement > net Income

-505000

Quarters > 2 > income Statement > eps

-0.011957757150975563

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

42232000

Quarters > 2 > income Statement > income Tax Expense

-1790000

Quarters > 2 > income Statement > EBITDA

10814000

Quarters > 2 > income Statement > operating Margin

2.167148255167815

Quarters > 2 > income Statement > total Other Income Expense Net

-4440000

Quarters > 2 > balance Sheet > cash

37693000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

95758000

Quarters > 2 > balance Sheet > inventories

81927000

Quarters > 2 > balance Sheet > total Current Assets

287297000

Quarters > 2 > balance Sheet > property Plant Equipment

77039000

Quarters > 2 > balance Sheet > total Assets

791163000

Quarters > 2 > balance Sheet > payables

11695000

Quarters > 2 > balance Sheet > short Term Debt

5379000

Quarters > 2 > balance Sheet > long Term Debt

314611000

Quarters > 2 > balance Sheet > total Liabilities

496911000

Quarters > 2 > balance Sheet > equity

294252000

Quarters > 2 > cash Flow > net Income

-505000

Quarters > 2 > cash Flow > depreciation

5446000

Quarters > 2 > cash Flow > change In Working Capital

-26756000

Quarters > 2 > cash Flow > cash From Operations

-16953000

Quarters > 2 > cash Flow > capital Expenditures

3638000

Quarters > 2 > cash Flow > cash From Investing

-3638000

Quarters > 2 > cash Flow > cash From Financing

3937000

Quarters > 2 > cash Flow > net Change In Cash

-15770000

Quarters > 2 > ratios > PE

-0.011957757150975563

Quarters > 2 > ratios > PB

6.475768524937807

Quarters > 2 > ratios > ROE

-0.17162160325163467

Quarters > 2 > ratios > ROA

-0.0638300830549457

Quarters > 2 > ratios > FCF

-20591000

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-0.2080361292408414

Quarters > 2 > health Score

16

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

97308000

Quarters > 3 > income Statement > cost Of Revenue

35806000

Quarters > 3 > income Statement > gross Profit

61502000

Quarters > 3 > income Statement > operating Expenses

58833000

Quarters > 3 > income Statement > operating Income

2669000

Quarters > 3 > income Statement > interest Expense

9742000

Quarters > 3 > income Statement > pretax Income

-16602000

Quarters > 3 > income Statement > net Income

-16483000

Quarters > 3 > income Statement > eps

-0.39355809178167234

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

41882000

Quarters > 3 > income Statement > income Tax Expense

-119000

Quarters > 3 > income Statement > EBITDA

-565000

Quarters > 3 > income Statement > operating Margin

2.742837176799441

Quarters > 3 > income Statement > total Other Income Expense Net

-19271000

Quarters > 3 > balance Sheet > cash

53463000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

85893000

Quarters > 3 > balance Sheet > inventories

79766000

Quarters > 3 > balance Sheet > total Current Assets

290080000

Quarters > 3 > balance Sheet > property Plant Equipment

76129000

Quarters > 3 > balance Sheet > total Assets

789101000

Quarters > 3 > balance Sheet > payables

17971000

Quarters > 3 > balance Sheet > short Term Debt

5285000

Quarters > 3 > balance Sheet > long Term Debt

314152000

Quarters > 3 > balance Sheet > total Liabilities

512901000

Quarters > 3 > balance Sheet > equity

276200000

Quarters > 3 > cash Flow > net Income

-16483000

Quarters > 3 > cash Flow > depreciation

6295000

Quarters > 3 > cash Flow > change In Working Capital

899000

Quarters > 3 > cash Flow > cash From Operations

10139000

Quarters > 3 > cash Flow > capital Expenditures

1425000

Quarters > 3 > cash Flow > cash From Investing

-11425000

Quarters > 3 > cash Flow > cash From Financing

174000

Quarters > 3 > cash Flow > net Change In Cash

-2710000

Quarters > 3 > ratios > PE

-0.39355809178167234

Quarters > 3 > ratios > PB

6.8418386676321505

Quarters > 3 > ratios > ROE

-5.96777697320782

Quarters > 3 > ratios > ROA

-2.0888327349730895

Quarters > 3 > ratios > FCF

8714000

Quarters > 3 > ratios > Piotroski FScore

2

Quarters > 3 > ratios > fcf Percent

0.08955070497800798

Quarters > 3 > health Score

25

Valuation > metrics > PE

0.13330599692465403

Valuation > metrics > PB

5.016544561813017

Valuation > final Score

49.83455438186983

Valuation > verdict

15.7% Undervalued

Profitability > metrics > ROE

1.4821264936379344

Profitability > metrics > ROA

2.2911549859577782

Profitability > metrics > Net Margin

0.0573429287049776

Profitability > final Score

18

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.9550347166817873

Risk > metrics > Interest Coverage

2.0487007680993625

Risk > final Score

56

Risk > verdict

High

Liquidity > metrics > Current Ratio

12.729299934031575

Liquidity > metrics > Quick Ratio

8.667803385117224

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

51.239685450414626

Prev Valuations > 1

20

Prev Valuations > 2

20

Prev Profitabilities > 0

4

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

53

Prev Risks > 1

31

Prev Risks > 2

31

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:13:55.599Z